REQUIP
GLAXOSMITHKLINE INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is REQUIP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that REQUIP 1MG has been permanently discontinued (last updated March 15, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is REQUIP not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TEVA-ROPINIROLE
TEVA CANADA LIMITED
Other Products
PHL-ROPINIROLE
PHARMEL INC
APO-ROPINIROLE
APOTEX INC
SPC-ROPINIROLE
SUN PHARMA CANADA INC
DOM-ROPINIROLE
DOMINION PHARMACAL
ROPINIROLE
SANIS HEALTH INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02232567
Strength
1MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ROPINIROLE
Tier
Unrated
Last Updated
2018-03-15
Reason for Shortage
Business reasons
Other Products from GLAXOSMITHKLINE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02245127
DIN 02245126
DIN 02240835
DIN 02240836
DIN 02240837
1MG · DIN 02237820
2.5MG · DIN 02237821
DIN 02418401
120MCG · DIN 02540207
100MCG · DIN 02446561
200MCG · DIN 02446588
27.5MCG · DIN 02298589